First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

Bằng Holleman, Marscha S, van Tinteren, Harm, Groen, Harry JM, Al, Maiwenn J, Uyl-de Groot, Carin A
Xuất bản năm Onco Targets Ther (2019)

Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations

Bằng Holleman, Marscha S., Al, Maiwenn J., Zaim, Remziye, Groen, Harry J. M., Uyl-de Groot, Carin A.
Xuất bản năm Eur J Health Econ (2019)